首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
【2h】

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC

机译:非小细胞肺癌中ALK基因扩增和拷贝数增益的不生产作用。 NSCLC中的ALK基因扩增和复制增益

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Anaplastic Lymphoma Kinase (ALK) gene is known to be affected by several genetic alterations, such as rearrangement, amplification and point mutation. The main goal of this study was to comprehensively analyze amplification ( -A) and gene copy number gain ( ) in a large cohort of non-small-cell lung cancer (NSCLC) patients in order to evaluate the effects on mRNA and protein expression. locus number status was evaluated in 578 NSCLC cases by fluorescence in situ hybridization (FISH). In addition, ALK immunohistochemistry and ALK mRNA in situ hybridization were performed. Out of 578 cases, 17 cases showed -A. In addition, 14 cases presented K-CNG and 72 cases presented chromosome 2 polyploidy. None of those carrying -A and -CNG showed either ALK immunohistochemical expression or ALK mRNA expression through in situ hybridization. We observed a high frequency of extra copies of the gene. : Our findings demonstrated that -A is not involved in mRNA production and consequently is not involved in protein production; these findings support the hypothesis that -A might not play a role in the pathogenesis of NSCLC, underlining the absence of a specific clinical application.
机译:已知共产淋巴瘤激酶(ALK)基因受几种遗传改变的影响,例如重排,扩增和点突变。本研究的主要目的是全面分析大型非小细胞肺癌(NSCLC)患者的扩增(-A)和基因拷贝数增益(),以评估对mRNA和蛋白表达的影响。 在原位杂交(鱼类)的荧光中,在578个NSCLC病例中评估了轨迹号状态。另外,进行alk免疫组织化合物和alk mRNA原位杂交。在578例中,17例显示-A。此外,14例呈现K-CNG和72例染色体2种多倍体。携带-A和-cng的那些载有ALK免疫组织化学表达或通过原位杂交表达。我们观察了基因额外额外拷贝的高频。 :我们的研究结果表明,-A不参与mRNA生产,因此不参与蛋白质生产;这些发现支持假设,即可能在NSCLC发病机制中发挥作用,强调没有特定的临床应用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号